📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Retargeting FX-binding-ablated HAdV-5 to vascular cells by inclusion of the RGD-4C peptide in hexon hypervariable region 7 and the HI loop. (2016)

First Author: Robertson S

Attributed to: Improved adenoviral gene therapy vectors via combined genetic modification of the adenovirus capsid to ablate interaction with blood coagulation facto funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1099/jgv.0.000505

PubMed Identifier: 27189759

Publication URI: http://europepmc.org/abstract/MED/27189759

Type: Journal Article/Review

Volume: 97

Parent Publication: The Journal of general virology

Issue: 8

ISSN: 0022-1317